Immatics (IMTX) Net Margin (2019 - 2025)

Immatics' (IMTX) quarterly Net Margin came in at 200.78% in Q4 2025, down 34909.0% year-on-year from N/an in Q4 2024, and up 79.5% quarter-over-quarter from 979.35% in Q3 2025.

Immatics (IMTX) Net Margin (2019 - 2025) Analysis & Trends

Immatics has disclosed Net Margin across 7 years of filings, most recently posting 200.78% for Q4 2025.

  • Net Margin for Q4 2025 came in at 200.78%, down 34909.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 425.0% (down 43948.0% YoY), and the FY2025 annual result was 407.01%, down 41677.0% from the prior year.
  • Net Margin came in at 200.78% for Q4 2025 at Immatics, up from 979.35% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 148.31% in Q4 2024 to a low of 1527.34% in Q2 2025.
  • The 5-year median for Net Margin is 140.55% (2023), against an average of 265.29%.
  • Across the five-year window, Net Margin surged 166083 bps in 2021 and plunged 143141 bps in 2025, its largest moves.
  • Immatics' Net Margin stood at 106.74% in 2021, then soared by 106 bps to 5.89% in 2022, then plunged by 2639 bps to 149.51% in 2023, then soared by 199 bps to 148.31% in 2024, then sank by 235 bps to 200.78% in 2025.
  • The last three Net Margin figures came in at 200.78% (Q4 2025), 979.35% (Q3 2025), and 1527.34% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.82%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 34.53%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Immatics 14.67 Bn 14.67 Bn - -200.78%

Historic Data

Download Data
DateValue
Dec 31, 2025 -200.78%
Sep 30, 2025 -979.35%
Jun 30, 2025 -1,527.34%
Mar 31, 2025 -214.48%
Dec 31, 2024 148.31%
Sep 30, 2024 -59.06%
Jun 30, 2024 -95.93%
Mar 31, 2024 -10.09%
Dec 31, 2023 -149.51%
Sep 30, 2023 -447.00%
Jun 30, 2023 -110.09%
Mar 31, 2023 -201.58%
Dec 31, 2022 5.89%
Sep 30, 2022 -131.60%
Jun 30, 2022 -67.91%
Mar 31, 2022 83.24%
Dec 31, 2021 -106.74%
Sep 30, 2021 -422.21%
Jun 30, 2021 -511.35%
Mar 31, 2021 -308.16%